Clinical efficacy and safety of TUERP in the treatment of BPH patients with acontractile detrusor
Li Guoqing
Pang Peng
Abstract：Objective:To investigate the clinical efficacy and safety of transurethral enucleation and resection of the prostate (TUERP)in the treatment of benign prostatic hyperplasia (BPH)patients with acontractile detrusor (ACD).Methods:Clinical parameters were analyzed in 36 BPH patients with ACD,and statistical analyses were conducted after recording the clinical outcomes before and after operation.The statistic analysis indexes included in-ternational prostate symptom score (IPSS),maximum flow (Qmax ),post void residual urine volume (PVR),and application of indwelling catheter.Results:The analysis results of clinical outcomes showed that after TUERP treat-ment,24 and 33 patients got normal voiding after three months and six months of follow-up periods,respectively. As compared with preoperative IPSS,Qmaxand PVR (25.7±4.4,3.4±2.9 mL/s,and 164.56±42.6 mL),they were significantly increased at 3rd month after surgery (11.30±1.30,15.44±2.98 mL/s,and <50 mL),and the follow-up data got more significant improvements at 6th month after surgery (10.7±4.4,18.44±3.18 mL/s,and<50 mL)(P<0.05 for all).Conclusions:TUERP is regarded as a fairly ideal method for BPH patients with ACD. However,the long-term efectiveness of TUERP is yet to be further proved by greater clinical experience with long-term follow-up period.
Keywords：prostatic hypertrophytransurethral enucleative resection of prostateacontractile detrusor
Publication Date：2016-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 240-242 )